Encompass Health (NYSE:EHC) Releases FY 2024 Earnings Guidance

Encompass Health (NYSE:EHC - Get Free Report) issued an update on its FY 2024 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of 4.190-4.330 for the period, compared to the consensus estimate of 4.190. The company issued revenue guidance of $5.3 billion-$5.4 billion, compared to the consensus revenue estimate of $5.3 billion. Encompass Health also updated its FY24 guidance to $4.19-$4.33 EPS.

Wall Street Analysts Forecast Growth

Several research firms have commented on EHC. Stephens reissued an "overweight" rating and set a $105.00 price objective on shares of Encompass Health in a report on Tuesday, August 6th. Truist Financial increased their price target on Encompass Health from $104.00 to $108.00 and gave the company a "buy" rating in a research note on Monday, October 14th. UBS Group lifted their price objective on Encompass Health from $100.00 to $110.00 and gave the stock a "buy" rating in a research note on Wednesday, September 25th. KeyCorp initiated coverage on Encompass Health in a research report on Friday, October 11th. They set an "overweight" rating and a $115.00 target price for the company. Finally, Leerink Partnrs upgraded shares of Encompass Health to a "strong-buy" rating in a research report on Wednesday, July 10th. Eight research analysts have rated the stock with a buy rating and three have given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus price target of $104.67.

Encompass Health Trading Down 0.4 %

EHC stock traded down $0.33 during midday trading on Monday, reaching $93.13. The company's stock had a trading volume of 1,279,158 shares, compared to its average volume of 627,938. Encompass Health has a 1 year low of $59.57 and a 1 year high of $98.74. The firm has a market capitalization of $9.37 billion, a price-to-earnings ratio of 23.76, a PEG ratio of 1.45 and a beta of 0.88. The stock has a fifty day simple moving average of $93.67 and a two-hundred day simple moving average of $88.39. The company has a debt-to-equity ratio of 1.08, a quick ratio of 1.35 and a current ratio of 1.35.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings results on Monday, August 5th. The company reported $1.11 earnings per share for the quarter, beating the consensus estimate of $1.01 by $0.10. The firm had revenue of $1.30 billion during the quarter, compared to the consensus estimate of $1.30 billion. Encompass Health had a net margin of 7.88% and a return on equity of 17.83%. The company's revenue was up 9.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.95 earnings per share. On average, equities research analysts predict that Encompass Health will post 4.18 EPS for the current year.

Encompass Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be issued a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.73%. The ex-dividend date is Thursday, January 2nd. Encompass Health's dividend payout ratio is currently 17.35%.

Encompass Health declared that its Board of Directors has authorized a stock buyback program on Wednesday, July 24th that allows the company to buyback $500.00 million in outstanding shares. This buyback authorization allows the company to purchase up to 5.4% of its stock through open market purchases. Stock buyback programs are generally an indication that the company's board of directors believes its shares are undervalued.

Insider Transactions at Encompass Health

In other Encompass Health news, CFO Douglas E. Coltharp sold 12,260 shares of Encompass Health stock in a transaction dated Tuesday, August 13th. The stock was sold at an average price of $86.34, for a total transaction of $1,058,528.40. Following the completion of the sale, the chief financial officer now owns 136,227 shares of the company's stock, valued at approximately $11,761,839.18. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 2.10% of the company's stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.